The role of complement C3 in the outcome of regional myocardial infarction

Area of Science:

• Cardiovascular Science
• Immunology
• Pathophysiology

Background:

• Coronary heart disease and myocardial ischemia are primary causes of heart failure.
• Myocardial fibrosis is a key characteristic of heart failure.
• The complement system, particularly C3, is implicated in inflammatory responses.

Purpose of the Study:

• To investigate the role of complement C3 in myocardial ischemia/reperfusion injury (IRI).
• To determine the impact of C3 deficiency on cardiac fibrosis and function post-IRI.

Main Methods:

• Utilized a murine model of myocardial IRI.
• Compared wild-type (WT) mice with mice genetically deficient in C3 (C3-/-).
• Assessed myocardial necrosis, cardiac fibrosis, and cardiac function four weeks after IRI.

Main Results:

• C3-/- mice exhibited reduced myocardial necrosis compared to WT mice following IRI.
• Four weeks post-ischemia, C3-/- mice showed significantly less cardiac fibrosis.
• C3-/- mice demonstrated better cardiac function compared to WT controls.

Conclusions:

• The innate immune response mediated by complement C3 contributes to necrotic cell death after IRI.
• C3 plays a significant role in the development of cardiac fibrosis.
• Targeting complement C3 may offer a therapeutic approach to mitigate post-infarction heart failure.